Author

Worapol Ngamcherdtrakul

PDX Pharmaceuticals (United States)ORCID 0000-0003-4187-7709Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alyssa Wallstrum· 1 shared Gordon MillsiD· 1 shared Moataz M. Reda· 1 shared Noah A. Crumrine· 1 shared Pramod KumariD· 1 shared Ruijie WangiD· 1 shared Tongchatra Watcharawittayakul· 1 shared Wassana YantaseeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alyssa Wallstrum

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintJul 15, 2026

High-Density Wild-Type IL-2 Nanoparticles Preferentially Enhance CD8⁺ T-Cell Expansion and Reprogram the Tumor Microenvironment

Ruijie Wang, Pramod Kumar, Noah A. Crumrine…·Wassana Yantasee

This paper develops IL2-NP nanoparticles that enhance CD8 T-cell expansion and reprogram the tumor microenvironment, showing efficacy in multiple cancer models.

DOI 10.64898/2026.07.14.738558

mouseproteomics

𝕏 PostBluesky